purchase customization

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Personalized Medicines
1.2 Key Market Segments
1.2.1 Personalized Medicines Segment by Type
1.2.2 Personalized Medicines Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Personalized Medicines Market Overview
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Personalized Medicines Market Competitive Landscape
3.1 Global Personalized Medicines Revenue Market Share by Company (2019-2025)
3.2 Personalized Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Personalized Medicines Market Size Sites, Area Served, Product Type
3.4 Personalized Medicines Market Competitive Situation and Trends
3.4.1 Personalized Medicines Market Concentration Rate
3.4.2 Global 5 and 10 Largest Personalized Medicines Players Market Share by Revenue
3.4.3 Mergers & Acquisitions, Expansion
4 Personalized Medicines Value Chain Analysis
4.1 Personalized Medicines Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 The Development and Dynamics of Personalized Medicines Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 Mergers & Acquisitions
5.5.2 Expansions
5.5.3 Collaboration/Supply Contracts
5.6 Industry Policies
6 Personalized Medicines Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Personalized Medicines Market Size Market Share by Type (2019-2025)
6.3 Global Personalized Medicines Market Size Growth Rate by Type (2019-2025)
7 Personalized Medicines Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Personalized Medicines Market Size (M USD) by Application (2019-2025)
7.3 Global Personalized Medicines Market Size Growth Rate by Application (2019-2025)
8 Personalized Medicines Market Segmentation by Region
8.1 Global Personalized Medicines Market Size by Region
8.1.1 Global Personalized Medicines Market Size by Region
8.1.2 Global Personalized Medicines Market Size Market Share by Region
8.2 North America
8.2.1 North America Personalized Medicines Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Personalized Medicines Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Personalized Medicines Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Personalized Medicines Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Personalized Medicines Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 3G Biotech
9.1.1 3G Biotech Personalized Medicines Basic Information
9.1.2 3G Biotech Personalized Medicines Product Overview
9.1.3 3G Biotech Personalized Medicines Product Market Performance
9.1.4 3G Biotech Personalized Medicines SWOT Analysis
9.1.5 3G Biotech Business Overview
9.1.6 3G Biotech Recent Developments
9.2 Quest Diagnostics
9.2.1 Quest Diagnostics Personalized Medicines Basic Information
9.2.2 Quest Diagnostics Personalized Medicines Product Overview
9.2.3 Quest Diagnostics Personalized Medicines Product Market Performance
9.2.4 Quest Diagnostics Personalized Medicines SWOT Analysis
9.2.5 Quest Diagnostics Business Overview
9.2.6 Quest Diagnostics Recent Developments
9.3 Laboratory Corporation of America
9.3.1 Laboratory Corporation of America Personalized Medicines Basic Information
9.3.2 Laboratory Corporation of America Personalized Medicines Product Overview
9.3.3 Laboratory Corporation of America Personalized Medicines Product Market Performance
9.3.4 Laboratory Corporation of America Personalized Medicines SWOT Analysis
9.3.5 Laboratory Corporation of America Business Overview
9.3.6 Laboratory Corporation of America Recent Developments
9.4 Abbott
9.4.1 Abbott Personalized Medicines Basic Information
9.4.2 Abbott Personalized Medicines Product Overview
9.4.3 Abbott Personalized Medicines Product Market Performance
9.4.4 Abbott Business Overview
9.4.5 Abbott Recent Developments
9.5 Agendia NV
9.5.1 Agendia NV Personalized Medicines Basic Information
9.5.2 Agendia NV Personalized Medicines Product Overview
9.5.3 Agendia NV Personalized Medicines Product Market Performance
9.5.4 Agendia NV Business Overview
9.5.5 Agendia NV Recent Developments
9.6 Asuragen Inc
9.6.1 Asuragen Inc Personalized Medicines Basic Information
9.6.2 Asuragen Inc Personalized Medicines Product Overview
9.6.3 Asuragen Inc Personalized Medicines Product Market Performance
9.6.4 Asuragen Inc Business Overview
9.6.5 Asuragen Inc Recent Developments
9.7 Becton Dickinson
9.7.1 Becton Dickinson Personalized Medicines Basic Information
9.7.2 Becton Dickinson Personalized Medicines Product Overview
9.7.3 Becton Dickinson Personalized Medicines Product Market Performance
9.7.4 Becton Dickinson Business Overview
9.7.5 Becton Dickinson Recent Developments
9.8 CardioDx Inc.
9.8.1 CardioDx Inc. Personalized Medicines Basic Information
9.8.2 CardioDx Inc. Personalized Medicines Product Overview
9.8.3 CardioDx Inc. Personalized Medicines Product Market Performance
9.8.4 CardioDx Inc. Business Overview
9.8.5 CardioDx Inc. Recent Developments
9.9 Foundation Medicine
9.9.1 Foundation Medicine Personalized Medicines Basic Information
9.9.2 Foundation Medicine Personalized Medicines Product Overview
9.9.3 Foundation Medicine Personalized Medicines Product Market Performance
9.9.4 Foundation Medicine Business Overview
9.9.5 Foundation Medicine Recent Developments
9.10 Qiagen
9.10.1 Qiagen Personalized Medicines Basic Information
9.10.2 Qiagen Personalized Medicines Product Overview
9.10.3 Qiagen Personalized Medicines Product Market Performance
9.10.4 Qiagen Business Overview
9.10.5 Qiagen Recent Developments
9.11 Siemens Healthcare
9.11.1 Siemens Healthcare Personalized Medicines Basic Information
9.11.2 Siemens Healthcare Personalized Medicines Product Overview
9.11.3 Siemens Healthcare Personalized Medicines Product Market Performance
9.11.4 Siemens Healthcare Business Overview
9.11.5 Siemens Healthcare Recent Developments
9.12 Amgen
9.12.1 Amgen Personalized Medicines Basic Information
9.12.2 Amgen Personalized Medicines Product Overview
9.12.3 Amgen Personalized Medicines Product Market Performance
9.12.4 Amgen Business Overview
9.12.5 Amgen Recent Developments
9.13 Bristol-Myers Squibb
9.13.1 Bristol-Myers Squibb Personalized Medicines Basic Information
9.13.2 Bristol-Myers Squibb Personalized Medicines Product Overview
9.13.3 Bristol-Myers Squibb Personalized Medicines Product Market Performance
9.13.4 Bristol-Myers Squibb Business Overview
9.13.5 Bristol-Myers Squibb Recent Developments
9.14 GE Healthcare
9.14.1 GE Healthcare Personalized Medicines Basic Information
9.14.2 GE Healthcare Personalized Medicines Product Overview
9.14.3 GE Healthcare Personalized Medicines Product Market Performance
9.14.4 GE Healthcare Business Overview
9.14.5 GE Healthcare Recent Developments
9.15 Pfizer
9.15.1 Pfizer Personalized Medicines Basic Information
9.15.2 Pfizer Personalized Medicines Product Overview
9.15.3 Pfizer Personalized Medicines Product Market Performance
9.15.4 Pfizer Business Overview
9.15.5 Pfizer Recent Developments
9.16 Sanofi
9.16.1 Sanofi Personalized Medicines Basic Information
9.16.2 Sanofi Personalized Medicines Product Overview
9.16.3 Sanofi Personalized Medicines Product Market Performance
9.16.4 Sanofi Business Overview
9.16.5 Sanofi Recent Developments
9.17 23andMe
9.17.1 23andMe Personalized Medicines Basic Information
9.17.2 23andMe Personalized Medicines Product Overview
9.17.3 23andMe Personalized Medicines Product Market Performance
9.17.4 23andMe Business Overview
9.17.5 23andMe Recent Developments
9.18 Illumina
9.18.1 Illumina Personalized Medicines Basic Information
9.18.2 Illumina Personalized Medicines Product Overview
9.18.3 Illumina Personalized Medicines Product Market Performance
9.18.4 Illumina Business Overview
9.18.5 Illumina Recent Developments
10 Personalized Medicines Regional Market Forecast
10.1 Global Personalized Medicines Market Size Forecast
10.2 Global Personalized Medicines Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Personalized Medicines Market Size Forecast by Country
10.2.3 Asia Pacific Personalized Medicines Market Size Forecast by Region
10.2.4 South America Personalized Medicines Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Personalized Medicines by Country
11 Forecast Market by Type and by Application (2025-2032)
11.1 Global Personalized Medicines Market Forecast by Type (2025-2032)
11.2 Global Personalized Medicines Market Forecast by Application (2025-2032)
12 Conclusion and Key Findings